Immune-Mediated Adverse Drug Reactions
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Many adverse drug reactions are mediated by the immune system. This can be because the therapeutic effect of the drug targets the immune system. For example, immunosuppressive drugs increase the risk of infections. It is paradoxical that some immunosuppressive drugs can lead to autoimmune reactions. Another mechanism by which drugs can cause an adverse reaction involves an idiosyncratic response to the drug such as an immune-mediated skin rash. These idiosyncratic drug reactions (IDRs) are difficult to study because of the paucity of valid animal models and their unpredictable nature. Therefore, much of our mechanistic knowledge of IDRs is based on inferences from the clinical characteristics of IDRs rather than on controlled mechanistic studies. In general, IDRs are associated with a delay between starting the drug and the onset of the adverse reaction, and the typical delay is different for different types of IDRs. In contrast, on rechallenge, there is usually a rapid onset of the adverse reaction, which is characteristic of an amnestic immune response. The absence of such a rapid response is usually considered evidence that an IDR is not immune-mediated; yet, there are immune-mediated IDRs that do not have an amnestic response. One possible reason for the lack of an amnestic response is if the IDR has a strong autoimmune component leading to deletion of autoimmune memory cells when the drug is withdrawn. Another interesting characteristic of IDRs is that there are many drugs that can cause different types of IDRs in different patients. A possible explanation is that although the immune response is induced by a drug, it is directed against an autoantigen, and interindividual differences in the immune repertoire determine which autoantigen and target organ are affected. Although testing these hypotheses represents a difficult challenge, the importance of these adverse reactions makes it a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527
Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3325 · Cited by 316
Research works printed but not linked: 125
- Pirmohamed M., 2004, Br. Med. J, 329, 15, 10.1136/bmj.329.7456.15 · DOI · Paper page
- Vaughan C. J., 2003, Am. J. Cardiol., 91, 23B, 10.1016/S0002-9149(02)03270-8 · DOI
- Clark A. R., 2007, Mol. Cell. Endocrinol., 275, 79, 10.1016/j.mce.2007.04.013 · DOI · Paper page
- Murphy K., 2008, Janeway’s Immunobiology
- Atzeni F., 2008, Clin. Exp. Rheumatol., 26, S67
- Cutolo M., 2008, Autoimmun. Rev., 8, 153, 10.1016/j.autrev.2008.07.010 · DOI
- Yale S. H., 1996, Mayo Clin. Proc., 71, 5, 10.4065/71.1.5 · DOI · Paper page
- de Gans J., 2002, N. Engl. J. Med., 347, 1549, 10.1056/NEJMoa021334 · DOI · Paper page
- Zwerner J., 2007, Dermatol. Ther., 20, 229, 10.1111/j.1529-8019.2007.00136.x · DOI
- Kang I., 2003, Curr. Opin. Rheumatol., 15, 528, 10.1097/00002281-200309000-00002 · DOI · Paper page
- Kitahara K., 2007, Curr. Opin. Rheumatol., 19, 238, 10.1097/BOR.0b013e328099af80 · DOI · Paper page
- Shepherd R. W., 2008, Am. J. Transplant., 8, 396, 10.1111/j.1600-6143.2007.02068.x · doi:10.1111/j.1600-6143.2007.02068.x
- Dantal J., 1998, Lancet, 351, 623, 10.1016/S0140-6736(97)08496-1 · DOI · Paper page
- Paul C. F., 2003, J. Invest. Dermatol., 120, 211, 10.1046/j.1523-1747.2003.12040.x · DOI
- Pichler W. J., 2006, Allergy, 61, 912, 10.1111/j.1398-9995.2006.01058.x · DOI · Paper page
- Karpusas M., 1998, Cell. Mol. Life Sci., 54, 1203, 10.1007/s000180050248 · DOI
- Chutaputti A., 2000, J. Gastroenterol. Hepatol., 15, E156, 10.1046/j.1440-1746.2000.02114.x · DOI
- Bermel R. A., 2007, Neurotherapeutics, 4, 633, 10.1016/j.nurt.2007.07.001 · DOI
- Shiffman M. L., 2004, Ann. Hepatol., 3, 5, 10.1016/S1665-2681(19)32118-0 · DOI
- Durelli L., 1999, J. Neurol. Sci., 162, 74, 10.1016/S0022-510X(98)00299-8 · doi:10.1016/s0022-510x(98)00299-8
- Dixon W. G., 2006, Arthritis Rheum., 54, 2368, 10.1002/art.21978 · DOI · Paper page
- Page A. V., 2008, Transplant. Proc., 40, 1768, 10.1016/j.transproceed.2008.03.102 · DOI
- Abunasser J., 2008, Chest, 134, 850, 10.1378/chest.08-0034 · doi:10.1378/chest.08-0034
- Gonnet-Gracia C., 2008, Clin. Exp. Rheumatol., 26, 401
- Lee S. J., 2005, J. Allergy Clin. Immunol., 116, 900, 10.1016/j.jaci.2005.03.028 · DOI
- Panes J., 2007, Drugs, 67, 2511, 10.2165/00003495-200767170-00005 · DOI
- Smolen J. S., 2008, Lancet, 371, 987, 10.1016/S0140-6736(08)60453-5 · DOI · Paper page
- Engelhardt B., 2008, Neurodegener. Dis., 5, 16, 10.1159/000109933 · DOI · Paper page
- Boren E. J., 2008, J. Autoimmun., 30, 90, 10.1016/j.jaut.2007.11.013 · DOI
- Martin S. I., 2006, Clin. Infect. Dis., 43, 16, 10.1086/504811 · DOI · Paper page
- Coles A. J., 2008, N. Engl. J. Med., 359, 1786, 10.1056/NEJMoa0802670 · DOI · Paper page
- Cheson B. D., 2008, N. Engl. J. Med., 359, 613, 10.1056/NEJMra0708875 · DOI · Paper page
- Brinkmann V., 2007, Pharmacol. Ther., 115, 84, 10.1016/j.pharmthera.2007.04.006 · DOI · Paper page
- Goetzl E. J., 2008, Biochim. Biophys. Acta, 1781, 503, 10.1016/j.bbalip.2008.03.001 · DOI
- Kappos L., 2006, N. Engl. J. Med., 355, 1124, 10.1056/NEJMoa052643 · DOI · Paper page
- Chalmers A., 1982, Ann. Intern. Med., 97, 659, 10.7326/0003-4819-97-5-659 · DOI
- Chin G., 1991, J. Rheumatol., 18, 947
- Donker A. J., 1984, Clin. Immunol. Immunopathol., 30, 142, 10.1016/0090-1229(84)90015-1 · DOI
- Jaffe I. A., 1981, Springer Semin. Immunopathol., 4, 193, 10.1007/BF01857095 · doi:10.1007/bf01857095
- Moore A. P., 1984, Br. Med. J. (Clin. Res. Ed.), 288, 192, 10.1136/bmj.288.6412.192-a · doi:10.1136/bmj.288.6412.192-a
- Elkayam O., 1999, Semin. Arthritis Rheum., 28, 392, 10.1016/S0049-0172(99)80004-3 · DOI · Paper page
- Rowley B., 2005, Mol. Immunol., 42, 833, 10.1016/j.molimm.2004.07.050 · DOI
- Vanheule B. A., 1983, Eur. J. Pediatr., 140, 66, 10.1007/BF00661910 · doi:10.1007/bf00661910
- Kromann N. P., 1982, Arch. Dermatol., 118, 531, 10.1001/archderm.1982.01650190085028 · doi:10.1001/archderm.1982.01650190085028
- Uetrecht J., 2007, Annu. Rev. Pharmacol. Toxicol., 47, 513, 10.1146/annurev.pharmtox.47.120505.105150 · DOI · Paper page
- Warkentin T. E., 2001, N. Engl. J. Med., 344, 1286, 10.1056/NEJM200104263441704 · DOI · Paper page
- Uetrecht J., 2008, Chem. Res. Toxicol., 21, 84, 10.1021/tx700186p · DOI · Paper page
- Valeyrie-Allanore L., 2007, Drug Saf., 30, 1011, 10.2165/00002018-200730110-00003 · DOI
- Nigen S., 2003, J. Drugs Dermatol., 2, 278
- Roujeau J. C., 2006, Allergol. Int., 55, 27, 10.2332/allergolint.55.27 · DOI
- Gomez M. B., 2004, Curr. Opin. Allergy Clin. Immunol., 4, 261, 10.1097/01.all.0000136764.74065.15 · DOI
- Parker C. W., 1963, J. Lab. Clin. Med., 62, 482
- Mathelier-Fusade P., 2006, Clin. Rev. Allergy Immunol., 30, 19, 10.1385/CRIAI:30:1:019 · DOI
- Lerch M., 2004, Curr. Opin. Allergy Clin. Immunol., 4, 411, 10.1097/00130832-200410000-00013 · DOI
- Bronnimann M., 2005, Curr. Opin. Allergy Clin. Immunol., 5, 317, 10.1097/01.all.0000173787.65777.77 · DOI
- Yawalkar N., 2005, Toxicology, 209, 131, 10.1016/j.tox.2004.12.023 · doi:10.1016/j.tox.2004.12.023
- Pichler W. J., 2003, Ann. Intern. Med., 139, 683, 10.7326/0003-4819-139-8-200310210-00012 · DOI · Paper page
- Sehgal V. N., 2006, Int. J. Dermatol., 45, 897, 10.1111/j.1365-4632.2006.02853.x · DOI
- Wolf R., 2005, Clin. Dermatol., 23, 311, 10.1016/j.clindermatol.2005.02.001 · doi:10.1016/j.clindermatol.2005.02.001
- Murata J., 2008, J. Allergy Clin. Immunol, 122, 992, 10.1016/j.jaci.2008.06.013 · doi:10.1016/j.jaci.2008.06.013
- Wolkenstein P., 1998, Lancet, 352, 1586, 10.1016/S0140-6736(98)02197-7 · DOI · Paper page
- Hung S. I., 2006, Pharmacogenet. Genomics, 16, 297, 10.1097/01.fpc.0000199500.46842.4a · DOI · Paper page
- Hung S. I., 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 4134, 10.1073/pnas.0409500102 · DOI · Paper page
- Zimmerman H., 1999, Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver
- Bjornsson E., 2005, Hepatology, 42, 481, 10.1002/hep.20800 · DOI · Paper page
- Bougie D. W., 2002, Blood, 100, 2071, 10.1182/blood.V100.6.2071 · doi:10.1182/blood.v100.6.2071
- Bourdi M., 1996, Chem. Res. Toxicol., 9, 1159, 10.1021/tx960083q · DOI · Paper page
- Lecoeur S., 1996, Mol. Pharmacol., 50, 326, 10.1016/S0026-895X(25)09234-X · DOI · Paper page
- Bourdi M., 1994, Mol. Pharmacol., 45, 1287, 10.1016/S0026-895X(25)10602-0 · DOI · Paper page
- Chabrol B., 1994, Eur. J. Pediatr., 153, 133
- Silva M. F., 2008, J. Inherited Metab. Dis., 31, 205, 10.1007/s10545-008-0841-x · DOI · Paper page
- Lee Y. H., 2008, Toxicol. Appl. Pharmacol., 231, 43, 10.1016/j.taap.2008.03.025 · DOI
- Ong M. M., 2007, Toxicol. Sci., 97, 205, 10.1093/toxsci/kfl180 · DOI · Paper page
- Seguin B., 2003, Curr. Opin. Allergy Clin. Immunol., 3, 235, 10.1097/00130832-200308000-00001 · DOI · Paper page
- Kindmark A., 2008, Pharmacogenomics J., 8, 186, 10.1038/sj.tpj.6500458 · DOI · Paper page
- Keisu M., Mechanisms of Adverse Drug Reactions
- Woosley R. L., 1978, N. Engl. J. Med., 298, 1157, 10.1056/NEJM197805252982101 · DOI · Paper page
- Uetrecht J. P., 1981, Clin. Pharmacokinet., 6, 118, 10.2165/00003088-198106020-00003 · doi:10.2165/00003088-198106020-00003
- Vergani D., 2008, World J. Gastroenterol., 14, 3306, 10.3748/wjg.14.3306 · doi:10.3748/wjg.14.3306
- Bernal W., 2007, J. Hepatol., 47, 664, 10.1016/j.jhep.2007.05.011 · DOI
- Clay K. D., 2006, Ann. Intern. Med., 144, 415, 10.7326/0003-4819-144-6-200503210-00121 · DOI · Paper page
- Watkins P. B., 2005, Toxicol. Pathol., 33, 1, 10.1080/01926230590888306 · DOI · Paper page
- Reid A. B., 2005, J. Pharmacol. Exp. Ther., 312, 509, 10.1124/jpet.104.075945 · DOI · Paper page
- Laskin D. L., 1995, Hepatology, 21, 1045, 10.1002/hep.1840210424 · DOI · Paper page
- Ju C., 2002, Chem. Res. Toxicol., 15, 1504, 10.1021/tx0255976 · DOI · Paper page
- Liu Z. X., 2004, Gastroenterology, 127, 1760, 10.1053/j.gastro.2004.08.053 · DOI · Paper page
- Masson M. J., 2008, Hepatology, 48, 889, 10.1002/hep.22400 · DOI · Paper page
- Watkins P. B., 2006, J. Am. Med. Assoc., 296, 87, 10.1001/jama.296.1.87 · DOI · Paper page
- Bourdi M., 2007, Chem. Res. Toxicol., 20, 208, 10.1021/tx060228l · DOI
- Aster R. H., 2005, Toxicology, 209, 149, 10.1016/j.tox.2004.12.031 · DOI
- Kramer M. R., 1986, Scand. J. Haematol., 36, 118, 10.1111/j.1600-0609.1986.tb02662.x · doi:10.1111/j.1600-0609.1986.tb02662.x
- Murphy W. G., 1988, Blood Rev., 2, 36, 10.1016/0268-960X(88)90006-9 · doi:10.1016/0268-960x(88)90006-9
- Worlledge S. M., 1973, Semin. Hematol., 10, 327
- Warkentin T. E., 2003, Br. J. Hamaetol., 121, 535, 10.1046/j.1365-2141.2003.04334.x · DOI · Paper page
- Aster R. H., 1999, Semin. Hematol., 36, 2
- Moeschlin S., 1952, Acta Haematol., 8, 29, 10.1159/000204146 · DOI · Paper page
- Salama A., 1989, Br. J. Hamaetol., 72, 127, 10.1111/j.1365-2141.1989.tb07672.x · DOI · Paper page
- Wall J. R., 1984, J. Clin. Endocrinol. Metab., 58, 868, 10.1210/jcem-58-5-868 · DOI · Paper page
- Fibbe W. E., 1986, Br. J. Hamaetol., 64, 363, 10.1111/j.1365-2141.1986.tb04130.x · DOI · Paper page
- Akamizu T., 2002, Clin. Exp. Immunol., 127, 92, 10.1046/j.1365-2249.2002.01720.x · DOI · Paper page
- Gardner I., 1998, Mol. Pharmacol., 53, 999, 10.1016/S0026-895X(24)13269-5 · DOI
- Marchesi C., 2005, J. Clin. Psychopharmacol., 25, 276, 10.1097/01.jcp.0000162814.99818.bb · doi:10.1097/01.jcp.0000162814.99818.bb
- Safferman A. Z., 1992, Lancet, 339, 1296, 10.1016/0140-6736(92)91625-I · doi:10.1016/0140-6736(92)91625-i
- Guest I., 1998, Toxicology, 131, 53, 10.1016/S0300-483X(98)00110-3 · doi:10.1016/s0300-483x(98)00110-3
- Williams D. P., 2000, Mol. Pharmacol., 58, 207, 10.1124/mol.58.1.207 · doi:10.1124/mol.58.1.207
- Husain Z., 2006, Toxicol. Appl. Pharmacol., 214, 326, 10.1016/j.taap.2006.01.008 · DOI
- Fehsel K., 2005, J. Clin. Psychopharmacol., 25, 419, 10.1097/01.jcp.0000177668.42640.fe · DOI
- Ip J., 2008, Chem. Res. Toxicol., 21, 874, 10.1021/tx7004037 · doi:10.1021/tx7004037
- Ip J., 2008, Chem. Res. Toxicol., 21, 869, 10.1021/tx7004025 · DOI
- Mosyagin I., 2004, J. Clin. Psychopharmacol., 24, 613, 10.1097/01.jcp.0000144891.52858.a6 · DOI
- Dettling M., 2001, Arch. Gen. Psychiatry, 58, 93, 10.1001/archpsyc.58.1.93 · DOI
- Dettling M., 2001, Pharmacogenetics, 11, 135, 10.1097/00008571-200103000-00004 · DOI
- Yunis J. J., 1995, Blood, 86, 1177, 10.1182/blood.V86.3.1177.1177 · DOI
- Young N., 1994, Aplastic Anemia: Acquired and Inherited
- Young N. S., 2008, Curr. Opin. Hematol., 15, 162, 10.1097/MOH.0b013e3282fa7470 · DOI · Paper page
- Uetrecht J. P., 1990, CRC Crit. Rev. Toxicol., 20, 213, 10.3109/10408449009089863 · DOI
- Kapetanovic I. M., 2002, Chem.-Biol. Interact., 142, 119, 10.1016/S0009-2797(02)00058-3 · DOI
- Scheinberg P., 2008, J. Pediatr., 153, 814, 10.1016/j.jpeds.2008.06.004 · DOI
- Sloand E., 2002, Blood, 100, 1185, 10.1182/blood-2002-01-0035 · DOI · Paper page
- Wiik A., 2008, Curr. Opin. Rheumatol., 20, 35, 10.1097/BOR.0b013e3282f1331f · DOI
- Sarzi-Puttini P., 2005, Autoimmunity, 38, 507, 10.1080/08916930500285857 · DOI
- Merkel P. A., 1998, Curr. Opin. Rheumatol., 10, 45, 10.1097/00002281-199801000-00007 · DOI
- Uetrecht J., 2005, Autoimmun. Rev., 4, 309, 10.1016/j.autrev.2005.01.002 · doi:10.1016/j.autrev.2005.01.002
- Masson M. J., 2004, J. Immunotoxicol., 1, 79, 10.1080/15476910490496258 · doi:10.1080/15476910490496258
- Richardson B., 2003, Clin. Immunol., 109, 72, 10.1016/S1521-6616(03)00206-7 · DOI · Paper page
Cited by
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
A Perspective on the Kinetics of Covalent and Irreversible Inhibition
Strelow, J. M. (2017) · SLAS Discovery · doi:10.1177/1087057116671509 · Cited by 392
“Some of these idiosyncratic events result in an immune response to the covalently modified cellular macromolecule.(14) The discovery of drugs that can be administered at lower doses could decrease the risk of these events.”
BackgroundStrategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
Guengerich, F. P. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-062 · Cited by 387
Flanagan, M. E., Abramite, J. A., Anderson, D. P., Aulabaugh, A., Dahal, U. P., Gilbert, A. M., Li, C., Montgomery, J., Oppenheimer, S. R., Ryder, T., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501412a · Cited by 320
Idiosyncratic Adverse Drug Reactions: Current Concepts
Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 310
Self-citationAn integrative machine learning approach for prediction of toxicity-related drug safety
Lysenko, A., Sharma, A., Boroevich, K. A., & Tsunoda, T. (2018) · Life Science Alliance · doi:10.26508/lsa.201800098 · Cited by 88
Li, W., Hu, Y., & Bischel, H. N. (2021) · Toxics · doi:10.3390/toxics9030063 · Cited by 53
Bashore, C., Jaishankar, P., Skelton, N. J., Fuhrmann, J., Hearn, B. R., Liu, P. S., Renslo, A. R., & Dueber, E. C. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00031 · Cited by 34
Metadata
- Authors
- Uetrecht, J.
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-12-12
- Volume
- 22
- Issue
- 1
- Pages
- 24-34
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2055409375
- Cited by
- 110
- References
- 8
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.